Qiming Venture Partners — 2023 Investments
8 investments dated 2023 · listed companies and verified rows first · show all
Allorion Therapeutics is a drug development company focused on advancing new therapeutics.
BiotechHealthtech
Fang Li(Founder)in
Co-investorsINCE Capital
DeepWay (深向) develops new-energy heavy-duty trucks and autonomous driving technology aimed at building unmanned freight robots (RoboTrucks) for logistics fleets.
AI & Machine LearningLogistics & Supply ChainMobility & TransportationBeijing, CN
Wan Jun(Founder)
Co-investorsBlue Lake Capital
MantaHealth provides an AI-powered platform for healthcare practices that automates insurance eligibility checks, prior authorizations, and patient out-of-pocket cost estimates.
AI & Machine LearningDigital HealthHealthtech
Allan Cutler(Founder)in
Co-investorsAmplify.LASevenX Ventures1843 CapitalBessemer Venture PartnersCoinFundCredo Ventures+4 more
MoodyTiger is a direct-to-consumer brand selling children's activewear and apparel, including knit jackets, brushed pants, and joggers for girls, designed for school, active play, and everyday layering.
ConsumerDirect to ConsumerE-commerceSports TechHong Kong, HK
Zoe NG(Founder)in
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Guangjing EnergySano DynamicsThorough Future
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.








